139 related articles for article (PubMed ID: 30214750)
1. Polymyositis as a manifestation of chronic graft-versus-host disease after allo-HSCT.
Meng L; Ji S; Wang Q; Bu B
Clin Case Rep; 2018 Sep; 6(9):1723-1726. PubMed ID: 30214750
[TBL] [Abstract][Full Text] [Related]
2. Polymyositis as a manifestation of chronic graft-versus-host disease.
Stevens AM; Sullivan KM; Nelson JL
Rheumatology (Oxford); 2003 Jan; 42(1):34-9. PubMed ID: 12509610
[TBL] [Abstract][Full Text] [Related]
3. Chronic graft-versus-host disease presenting as acute polymyositis: A case series and systematic review.
Shahzad M; Chaudhary SG; Basit A; Thellman C; Rodriguez L; Abhyankar SH; McGuirk JP; Mushtaq MU
Transpl Immunol; 2022 Feb; 70():101520. PubMed ID: 34952168
[TBL] [Abstract][Full Text] [Related]
4. Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation.
Ijaz A; Khan AY; Malik SU; Faridi W; Fraz MA; Usman M; Tariq MJ; Durer S; Durer C; Russ A; Parr NNC; Baig Z; Sagar F; Ali Z; McBride A; Anwer F
Biol Blood Marrow Transplant; 2019 Jan; 25(1):94-99. PubMed ID: 30195074
[TBL] [Abstract][Full Text] [Related]
5. Combination of anti-CD4 antibody treatment and donor lymphocyte infusion ameliorates graft-versus-host disease while preserving graft-versus-tumor effects in murine allogeneic hematopoietic stem cell transplantation.
Ueha S; Yokochi S; Ishiwata Y; Kosugi-Kanaya M; Shono Y; Shibayama S; Ito S; Matsushima K
Cancer Sci; 2017 Oct; 108(10):1967-1973. PubMed ID: 28787768
[TBL] [Abstract][Full Text] [Related]
6. Acute polymyositis after donor lymphocyte infusion.
Lin PC; Hsiao LT; Chen PM
Eur J Haematol; 2005 Feb; 74(2):166-8. PubMed ID: 15654909
[TBL] [Abstract][Full Text] [Related]
7. Relapsing polymyositis in chronic graft versus host disease.
Sharaf N; Prayson RA
J Clin Neurosci; 2014 Nov; 21(11):1964-5. PubMed ID: 24980629
[TBL] [Abstract][Full Text] [Related]
8. Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India.
Khan R; Nair S; Seth T; Mishra P; Mahapatra M; Agarwal T; Tandon R; Vanathi M
Indian J Med Res; 2015 Nov; 142(5):543-8. PubMed ID: 26658588
[TBL] [Abstract][Full Text] [Related]
9. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
10. Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation.
Yu J; Parasuraman S; Shah A; Weisdorf D
Curr Med Res Opin; 2019 Jun; 35(6):983-988. PubMed ID: 30461314
[TBL] [Abstract][Full Text] [Related]
11. S1PR5 regulates NK cell responses in preventing graft-versus-host disease while preserving graft-versus-tumour activity in a murine allogeneic haematopoietic stem cell transplantation model.
Wang F; Zhao S; Gu Z; Zhao X; Yang N; Guan L; Liu T; Wang L; Fang S; Zhu C; Luo L; Li M; Wang L; Gao C
Hematol Oncol; 2020 Feb; 38(1):89-102. PubMed ID: 31465552
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
[TBL] [Abstract][Full Text] [Related]
13. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
14. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
[TBL] [Abstract][Full Text] [Related]
15. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P
Front Immunol; 2021; 12():605766. PubMed ID: 34025637
[TBL] [Abstract][Full Text] [Related]
16. The composition of the intestinal microbiota after allogeneic haematopoietic stem cell transplantation and its association with graft versus host disease as assessed by 16Sribosomal ribonucleic acid.
Li DS; Wu YR; Du WH; Zhu YL; Zhang WJ; Fu Y; Yang GB
J Physiol Pharmacol; 2023 Feb; 74(1):. PubMed ID: 37245237
[TBL] [Abstract][Full Text] [Related]
17. Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation.
Khuat LT; Le CT; Pai CS; Shields-Cutler RR; Holtan SG; Rashidi A; Parker SL; Knights D; Luna JI; Dunai C; Wang Z; Sturgill IR; Stoffel KM; Merleev AA; More SK; Maverakis E; Raybould HE; Chen M; Canter RJ; Monjazeb AM; Dave M; Ferrara JLM; Levine JE; Longo DL; Abedi M; Blazar BR; Murphy WJ
Sci Transl Med; 2020 Nov; 12(571):. PubMed ID: 33239390
[TBL] [Abstract][Full Text] [Related]
18. Cecum ulcer is a reliable endoscopic finding in cytomegalovirus colitis concomitant with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Matsuda K; Ono S; Ishikawa M; Miyamoto S; Abiko S; Tsuda M; Yamamoto K; Kudo T; Shimizu Y; Hayase E; Hashimoto D; Teshima T; Matsuno Y; Sakamoto N
Ann Hematol; 2018 May; 97(5):877-883. PubMed ID: 29340759
[TBL] [Abstract][Full Text] [Related]
19. Chronic Graft-Versus-Host-Disease-Related Polymyositis: a 17-Months-Old Child with a Rare and Late Complication of Haematopoietic Stem Cell Transplantation.
Chinello M; Balter R; De Bortoli M; Vitale V; Zaccaron A; Bonetti E; Tonin P; Vattemi G; Guglielmi V; Cesaro S
Mediterr J Hematol Infect Dis; 2020; 12(1):e2020002. PubMed ID: 31934312
[TBL] [Abstract][Full Text] [Related]
20. Blockade of Vascular Endothelial Growth Factor (VEGF) Aggravates the Severity of Acute Graft-versus-host Disease (GVHD) after Experimental Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT).
Kim AR; Lim JY; Jeong DC; Park G; Lee BC; Min CK
Immune Netw; 2011 Dec; 11(6):368-75. PubMed ID: 22346777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
